Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 125
Single User License Price INR 8578
Corporate User License Price USD 375
Corporate User License Price INR 25733
Site License Price USD 250
Site License Price INR 17155
Request a Quote

Report Title

Chembio Diagnostic Inc (CEMI) - Financial and Strategic SWOT Analysis Review

Quote Request for License Type
License Type Price  
Single User License USD 125
Site License USD 250
Enterprise Wide License USD 375
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Chembio Diagnostic Inc (CEMI) - Financial and Strategic SWOT Analysis Review


Quote Request for License Type
License Type Price  
Single User License USD 125
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Chembio Diagnostic Inc (CEMI) - Financial and Strategic SWOT Analysis Review

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Chembio Diagnostic Inc (CEMI) - Financial and Strategic SWOT Analysis Review



Executive Summary

Chembio Diagnostic Inc (CEMI)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Chembio Diagnostic Inc (Chembio) develops, manufactures, markets and licenses point-of-care diagnostic (POCs) tests for the detection of infectious diseases. The company offers products to prevent the spread of infectious diseases with solutions like Dual Path Platform (DPP). Its DPP technology is used to treat infectious diseases such as HIV, Ebola, syphilis, Zika, malaria and febrile illness. Chembio also offers veterinary diagnostics. The company offers its products to medical laboratories and hospitals, non-governmental organizations, governmental and public health entities, medical professionals and retailers. The company distributes its products through a network of distributors worldwide. Chembio is headquartered in Medford, New York, the US.

Chembio Diagnostic Inc Key Recent Developments

Jul 28,2018: Chembio Diagnostics Announces Collaboration with FIND to Develop Hepatitis C Virus Point-of-Care Diagnostic Test

Jul 19,2018: Chembio Diagnostics names Christine Rousseau as vice president, corporate development

May 16,2018: Chembio Diagnostics Names John Potthoff, Ph.D. to its Board of Directors

May 09,2018: Chembio Diagnostics Reports First Quarter 2018 Financial Results

Mar 08,2018: Chembio Diagnostics Reports Fourth Quarter and Full Year 2017 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1-About the Company 5

Chembio Diagnostic Inc-Key Facts 5

Chembio Diagnostic Inc-Key Employees 6

Chembio Diagnostic Inc-Key Employee Biographies 7

Chembio Diagnostic Inc-Major Products and Services 9

Chembio Diagnostic Inc-History 10

Chembio Diagnostic Inc-Company Statement 13

Chembio Diagnostic Inc-Locations And Subsidiaries 14

Head Office 14

Other Locations & Subsidiaries 14

Section 2-Company Analysis 15

Company Overview 15

Chembio Diagnostic Inc-Business Description 16

Chembio Diagnostic Inc-SWOT Analysis 17

SWOT Analysis-Overview 17

Chembio Diagnostic Inc-Strengths 17

Chembio Diagnostic Inc-Weaknesses 18

Chembio Diagnostic Inc-Opportunities 19

Chembio Diagnostic Inc-Threats 20

Chembio Diagnostic Inc-Key Competitors 21

Section 3-Company Financial Ratios 22

Financial Ratios-Capital Market Ratios 22

Financial Ratios-Annual Ratios 23

Performance Chart 26

Financial Performance 26

Financial Ratios-Interim Ratios 27

Financial Ratios-Ratio Charts 28

Section 4-Company's Lifesciences Financial Deals and Alliances 29

Chembio Diagnostic Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 29

Chembio Diagnostic Inc, Medical Equipment, Deals By Type, 2012 to YTD 2018 30

Chembio Diagnostic Inc, Recent Deals Summary 31

Section 5-Company's Recent Developments 32

Jul 19, 2018: Chembio Diagnostics names Christine Rousseau as vice president, corporate development 32

May 16, 2018: Chembio Diagnostics Names John Potthoff, Ph.D. to its Board of Directors 33

May 09, 2018: Chembio Diagnostics Reports First Quarter 2018 Financial Results 34

Mar 08, 2018: Chembio Diagnostics Reports Fourth Quarter and Full Year 2017 Financial Results 35

Dec 20, 2017: Chembio Diagnostics Announces Appointment of Neil A. Goldman as Chief Financial Officer 37

Dec 20, 2017: Chembio Diagnostics Announces Appointment of Neil A. Goldman as Chief Financial Officer 38

Nov 08, 2017: Chembio Diagnostics Reports Third Quarter 2017 Financial Results 39

Sep 08, 2017: Ginolis Rapid Test Assembly System Selected by Chembio Diagnostics 41

Aug 17, 2017: Chembio Diagnostics Announces Retirement of Chief Financial Officer 42

Aug 09, 2017: Chembio Diagnostics Reports Second Quarter 2017 Financial Results 43

Section 6-Appendix 45

Methodology 45

Ratio Definitions 45

About GlobalData 49

Contact Us 49

Disclaimer 49

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures

Chembio Diagnostic Inc, Performance Chart (2013-2017) 26

Chembio Diagnostic Inc, Ratio Charts 28

Chembio Diagnostic Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 29

Chembio Diagnostic Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 30

List of Tables

Chembio Diagnostic Inc, Key Facts 5

Chembio Diagnostic Inc, Key Employees 6

Chembio Diagnostic Inc, Key Employee Biographies 7

Chembio Diagnostic Inc, Major Products and Services 9

Chembio Diagnostic Inc, History 10

Chembio Diagnostic Inc, Subsidiaries 14

Chembio Diagnostic Inc, Key Competitors 21

Chembio Diagnostic Inc, Ratios based on current share price 22

Chembio Diagnostic Inc, Annual Ratios 23

Chembio Diagnostic Inc, Annual Ratios (Cont...1) 24

Chembio Diagnostic Inc, Annual Ratios (Cont...2) 25

Chembio Diagnostic Inc, Interim Ratios 27

Chembio Diagnostic Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 29

Chembio Diagnostic Inc, Medical Equipment, Deals By Type, 2012 to YTD 2018 30

Chembio Diagnostic Inc, Recent Deals Summary 31

Currency Codes 45

Capital Market Ratios 45

Equity Ratios 46

Profitability Ratios 46

Cost Ratios 47

Liquidity Ratios 47

Leverage Ratios 48

Efficiency Ratios 48

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Roche Molecular Systems Inc

Response Genetics Inc

OraSure Technologies Inc

Maxim Biomedical Inc

Corgenix Medical Corp

bioLytical Laboratories Inc

Chembio Diagnostic Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand

person